Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
about
Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infectionGene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer.Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1.Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells.Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in miceOlfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancer.Plasma levels of OLFM4 in normals and patients with gastrointestinal cancerEstrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer.Loss of OLFM4 promotes tumor migration through inducing interleukin-8 expression and predicts lymph node metastasis in early gastric cancerBCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes.Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling.Mass spectrometry-based proteomic analysis of formalin-fixed paraffin-embedded extrahepatic cholangiocarcinoma.Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics.OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.Olfactomedin-4 in digestive diseases: A mini-review.Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD.Identification of differentially-expressed of Olfactomedin-related proteins 4 and COL11A1 in Iranian patients with intestinal gastric cancer.
P2860
Q28512523-017317CD-DC37-4FFC-A566-61BAE5590D1EQ33557996-4B98F6F4-BAE3-4BD0-A33F-DD9E2875DAE2Q33991653-FF1F7E67-D0AD-4A26-B89E-6129EADB0A65Q34116120-1C87FEBC-0F1C-4873-AE7C-488BF3FB9822Q34254533-89BD1B25-12DA-4873-AF51-CE02D4DD4A10Q34450695-230E5962-81E2-47F1-B6EF-F54AAA7AD3D2Q35000190-4F1A6416-2824-4FAE-A09E-1BB4514F1427Q35083529-49755F60-5B82-417F-8923-38C0E322D471Q35984391-2B5995FB-579C-4561-8280-3EC58BD79478Q36179723-6680E54F-FA41-44C8-AE88-4DC7C4AB6571Q36297949-2524153B-815E-46AE-9736-2E4F21C6913EQ36355626-4611A18B-C33F-4D86-9693-8EB929713589Q36375217-E78B26D8-A2B4-4B1A-8254-09CFDF308C7EQ36394711-37E72B92-6BA2-4841-813F-E4133F2A9B6FQ36963041-5F1E3F05-BBEF-478C-821F-E1D9683A3563Q37096228-B3817DD5-2AC7-4CAD-849D-6C400D0DAD00Q37177907-06CE9757-2BF7-409C-A944-1B4205A838A2Q37462019-56390997-B357-4BFF-A342-71A88231725BQ38268568-BFBF9B2F-3F04-4239-BA52-1EB91A678103Q38834179-9F9FF053-CA8E-4F37-9C84-605109E98BCCQ38841122-E9AABB4E-8EB0-4783-872F-6AE5F0F5FD16Q39013668-1D6130C2-5DA2-4433-926E-68B5C6E09D11Q41673477-080C988E-87EF-46E2-A58F-7FBA392B10E4Q51510767-E5073F07-B059-4D46-964C-16E17E7DFABEQ53281954-7958633C-851F-44F3-BC02-12A47BC61783Q54217687-90354540-54DB-487D-BBA1-3FD9D00B36BAQ54320285-66657B1D-234A-41DC-93A2-423A63F97588Q54994960-3BB2D39B-3766-4FB7-A171-2F23423C3442
P2860
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
@en
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
@nl
type
label
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
@en
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
@nl
prefLabel
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
@en
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
@nl
P2093
P2860
P1433
P1476
Expression of hGC-1 is correlated with differentiation of gastric carcinoma.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.2007.02763.X
P577
2007-08-01T00:00:00Z